GATA binding protein 4 promotes the expression and transcription of hepatitis B virus by facilitating hepatocyte nuclear factor 4 alpha in vitro
GATA binding protein 4 (GATA4) has been reported as a potential target of gene therapy for hepatocellular carcinoma (HCC). It is well known that the main cause of HCC is the chronic infection of hepatitis B vi...
Source: Virology Journal - Category: Virology Authors: Xiaoqin Lv, Xia Xiang, Yue Wu, Yang Liu, Ruqing Xu, Qin Xiang and Guoqi Lai Tags: Research Source Type: research
More News: Cancer & Oncology | Carcinoma | Gene Therapy | Genetics | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver Cancer | Virology